ViQi and Araceli Biosciences collaborated to integrate ViQi’s AI-powered image analysis with Araceli’s high-throughput imaging platform.
ViQi, Inc. and Araceli Biosciences announced a dynamic collaboration to leverage ViQi’s revolutionary AI-driven image analysis technology with Araceli’s unmatched imaging innovations of their cutting-edge Araceli Endeavor® Ultra High Throughput – High Content Imaging Platform to advance AI-driven phenotypic profiling in high throughput (HTP) cell-based assays. This collaboration will both align efforts to bring novel imaging assays to market as well as transform how cutting-edge technology is showcased, celebrated, and embraced by the scientific community.
“This collaboration enables ViQi to further serve customers by offering a coordinated effort to not only meaningfully analyze terabytes of imaging data but to enable scientific labs to generate this large amount of data in the first place,” said Kathy Yeung, ViQi’s CEO. “Using AI-driven analysis has proven to be increasingly valuable. The Endeavor’s speed to generate a lot of high quality image data means ViQi’s predictive AI technology can draw out meaningful insights that wouldn’t otherwise be realized.”
Also Read: Clario & AWS Partner on GenAI for Clinical Data Analysis
Matt Beaudet, CEO of Araceli added “As biological datasets grow exponentially, the challenge isn’t just capturing more data—it’s making it usable in real time. At Araceli, we’re focused on enabling both speed and clarity, and we partner with innovators who push that boundary.
ViQi‘s platform is a standout—bringing structure, speed, and insight to complex phenotypic data. We’re excited to see what their customers can unlock with Endeavor fueling the front end.”
Source: PRweb
